STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
企業コードSTAA
会社名STAAR Surgical Co
上場日Feb 24, 1992
最高経営責任者「CEO」Farrell (Stephen C)
従業員数1157
証券種類Ordinary Share
決算期末Feb 24
本社所在地1911 Walker Ave
都市MONROVIA
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号91016
電話番号16263037902
ウェブサイトhttps://www.staar.com/
企業コードSTAA
上場日Feb 24, 1992
最高経営責任者「CEO」Farrell (Stephen C)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし